Physician profile
Mohammed Jaleel
NPI 1568425346
$938.65
in general payments reported to CMS, 2019-2025
12 companies · $95.33 in 2025
The $95.33 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2022: $141 · 2023: $412 · 2024: $159 · 2025: $95.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $241.30 | 2023 | Nuplazid |
| Janssen Pharmaceuticals, INC | $174.54 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $138.03 | 2023-2025 | Rexulti |
| Abbvie INC. | $112.16 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $104.19 | 2024-2025 | |
| Sunovion Pharmaceuticals INC. | $66.30 | 2019 | |
| Exact Sciences Corporation | $23.00 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.86 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.86 | 2025 | Eliquis |
| Tolmar, INC. | $16.01 | 2023 | |
| Pfizer INC. | $13.77 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Jaleel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.